MultiplexDX
Slovakia, SK · Founded 2015 · 44 employees on LinkedIn · 2 known investors
Find your way into MultiplexDX
MultiplexDX develops a molecular diagnostics platform for cancer detection using proprietary technologies that combine histopathology, biomarker quantification, and gene expression analysis. The company serves research institutions and clinical laboratories internationally, with a focus on improving diagnostic accuracy in oncology.
Founders & leadership
MultiplexDX was founded in 2015 by Dr. Pavol Cekan.
DP
Dr. Pavol Cekan𝕏Founder and CEO
Investors · 2
Frequently asked questions
- What does MultiplexDX do?
- MultiplexDX develops a molecular diagnostics platform for cancer detection using proprietary technologies that combine histopathology, biomarker quantification, and gene expression analysis. The company serves research institutions and clinical laboratories internationally, with a focus on improving diagnostic accuracy in oncology.
- Who founded MultiplexDX?
- MultiplexDX was founded by Dr. Pavol Cekan in 2015.
- Who are MultiplexDX's investors?
- MultiplexDX's investors include Neulogy Ventures, Crowdberry.
- Where is MultiplexDX headquartered?
- MultiplexDX is headquartered in Slovakia, SK.